Pharmaceutical versions of GLP-1, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), were initially developed to treat type 2 diabetes but are now widely prescribed for weight loss and other health conditions
Benefits toward weight loss are indirect-just through better energy and better mood levels, thus facilitating exercise performance and motivation
Functionally verifying the incretin receptor-dependent nature of the molecule, GLP-1GIPLani decreased body weight, food intake and blood glucose in DIO wild-type mice, and these effects were absent in DIO DIR-knockout mice (Fig
Multiple systematic reviews and meta-analyses have been conducted, with most indicating no significant difference in fracture risk between GLP-1Ra and placebo or other anti-diabetic medications [75,76,77]
8423, Rojo De La Vega, Montserrat, et al
The L subunit is encoded by the DLD gene